LAVA Therapeutics N.V. (LVTX)

NASDAQ: LVTX · IEX Real-Time Price · USD
2.95
-0.06 (-1.99%)
Jun 30, 2022 11:35 AM EDT - Market closed

Stock Price Forecast

According to 10 stock analysts, the average 12-month stock price forecast for LVTX stock is $23.12, which predicts an increase of 683.73%. The lowest target is $20.2 and the highest is $26.25. On average, analysts rate LVTX stock as a buy.
Analyst Consensus: Buy
Target Low Average Median High
Price $20.2 $23.12 $23.46 $26.25
Change +584.75% +683.73% +695.25% +789.83%

Analyst Ratings

The average analyst rating for LVTX stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '22Feb '22Mar '22Apr '22May '22Jun '22
Strong Buy 555555
Buy 444444
Hold 111111
Sell 000000
Strong Sell 000000
Total 101010101010

Financial Forecast

Revenue This Year
2.02M
Decreased by -59.66%
Revenue Next Year
n/a
EPS This Year
-1.99
EPS Next Year
-2.12
Year 20192020202120222023202420252026
Revenue
-3.50M5.00M2.02M----
Revenue Growth
--
42.86%
-59.66%
----
EPS
-21.65-38.85-2.30-1.99-2.12-1.96-1.93-1.94
EPS Growth
--------
No. Analysts ---55422

Revenue Forecast

Revenue 20222023202420252026
High 4.2M n/a n/a n/a n/a
Avg 2.0M n/a n/a n/a n/a
Low 913,076 n/a n/a n/a n/a

Revenue Growth

Revenue Growth 20222023202420252026
High
-6.9%
- - - -
Avg
-55.3%
- - - -
Low
-79.8%
- - - -

EPS Forecast

EPS 20222023202420252026
High -1.82 -1.85 -1.75 -2.03 -2.02
Avg -1.99 -2.12 -1.96 -1.93 -1.94
Low -2.16 -2.51 -2.13 -1.87 -1.88

EPS Growth

EPS Growth 20222023202420252026
High - - - - -
Avg - - - - -
Low - - - - -